Antibiotics for ventilator-associated pneumonia

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 10, 2016, Pages

  Arthur, Lauren E ^a   Kizor, Russell S ^a   Selim, Adrian G ^b   van Driel, Mieke L ^a,b,c   Seoane, Leonardo ^d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b BOND UNIVERSITY   (Australia)

^c GHENT UNIVERSITY   (Belgium)

^d OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; DORIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ANTIBIOTIC THERAPY; COMPARATIVE STUDY; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; META ANALYSIS (TOPIC); MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUPERINFECTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VENTILATOR ASSOCIATED PNEUMONIA; ADULT; CAUSE OF DEATH; COMBINATION DRUG THERAPY; EMPIRICAL RESEARCH; META ANALYSIS; PNEUMONIA, VENTILATOR-ASSOCIATED;

ADULT; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CAUSE OF DEATH; DRUG THERAPY, COMBINATION; EMPIRICAL RESEARCH; HUMANS; PNEUMONIA, VENTILATOR-ASSOCIATED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84991471663     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004267.pub4     Document Type: Review

References (52)

1. Alvarez Lerma F, Serious Infections Study Group. Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia. Journal of Chemotherapy 2001;13(1):70-81. [4438450]
2. Awad SS, Rodriguez AH, Chuang YC, Marjanek Z, Pareigis AJ, Reis G, et al. A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia. Clinical Infectious Diseases 2014;59(1):51-61. [4438452]
3. Beaucaire G, Nicolas MH, Martin C, Offenstadt G, Philippon A, Holzapfel L, et al. Comparative study of the association cefepime-amikacin versus the association ceftazidime-amikacin in the treatment of nosocomial pneumonias in ventilated patients [Etude comparative de l'association céfépime-amikacine versus ceftazidime en association avec l'amikacine dans le traitement des pneumonies nosocomiales chez les patients ventilés]. Annales Françaises d'Anesthésie et de Réanimation 1999;18:186-95. [4438454]
4. Brun-Buisson C, Sollet JP, Schweich H, Brière S, Petit C. Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. Clinical Infectious Diseases 1998;26:346-54. [4438456]
5. Damas P, Garweg C, Monchi M, Nys M, Canivet JL, Ledoux D, et al. Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]. Critical Care 2006;10(2):R52. [4438458]
6. Freire AT, Melnyk V, Kim MJ, Datsenko O, Dzyublik O, Glumcher F, et al. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia. Diagnostic Microbiology and Infectious Disease 2010;68(2):140-51. [4438460]
7. Heyland DK, Dodek P, Muscedere J, Day A, Cook D, Canadian Critical Care Trials Group. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Critical Care Medicine 2008;36(3):737-44. [4438462]
8. Kollef MH, Rello J, Cammarata SK, Croos-Dabrera RV, Wunderink RG. Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Medicine 2004;30(3):388-94. [4438464]
9. Rubinstein E, Cammarata S, Oliphant T, Wunderink R, Linezolid Nosocomial Pneumonia Study Group. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clinical Infectious Diseases 2001;32(3):402-12. [4438465]
10. Wunderink RG, Cammarata SK, Oliphant TH, Kollef MH, Linezolid Nosocomial Pneumonia Study Group. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clinical Therapeutics 2003;25(3):980-92. [4438466]
11. Kollef MH, Chastre J, Clavel M, Restrepo MI, Michiels B, Kaniga K, et al. A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Critical Care 2012;16(6):R218. [4438468]
12. Ramirez J, Dartois N, Gandjini H, Yan JL, Korth-Bradley J, McGovern PC. Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia. Antimicrobial Agents and Chemotherapy 2013;57(4):1756-62. [4438470]
13. Réa-Neto A, Niederman M, Lobo SM, Schroeder E, Lee M, Kaniga K, et al. Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study. Current Medical Research and Opinion 2008;24(7):2113-26. [4438472]
14. Shorr AF, Zadeikis N, Jackson WL, Ramage AS, Wu SC, Tennenberg AM, et al. Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial. Clinical Infectious Diseases 2005;40(Suppl):123-9. [4438474]
15. West M, Boulanger BR, Fogarty C, Tennenberg A, Wiesinger B, Oross M, et al. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study. Clinical Therapeutics 2003;25(2):485-506. [4438475]
16. Amonova DS, Ibadova DN. Clinical and bacteriological efficiency of two modes of ceftazidim and aminkacin dosing in patients with ventilator-associated pneumonia. Likars'ka Sprava / Ministerstvo Okhorony Zdorov'ia Ukrainy 2011;1-2:110-7. [4438477]
17. Barriere SL. The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia. Future Microbiology 2014;9(3):281-9. [4438479]
18. Bassetti M, Righi E, Fasce R, Molinari MP, Rosso R, Di Biagio A, et al. Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum beta-lactamase-producing organisms in an intensive care unit. Journal of Antimicrobial Chemotherapy 2007;60(2):433-5. [4438481]
19. Chastre J, Wunderink R, Prokocimer P, Lee M, Kaniga K, Friedland I. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Critical Care Medicine 2008;36(4):1089-96. [4438483]
20. Giamerellos-Bourboulis E, Pechere J, Routsi C, Plachouras D, Kollias S, Raftogiannis M, et al. Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. Clinical Infectious Diseases 2005;46(8):1157-64. [4438485]
21. Iakovlev SV, Beloborodov VB, Sidorenko SV, Iakovlev VP, Grigor'ev KB, Eliseeva EV, et al. Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis. Antibiotiki i Khimioterapiia 2006;51(7):15-27. [4438487]
22. Klapdor B, Ewig S. Ventilator associated pneumonia [Ventilator-assoziierte Pneumonie]. Deutsche Medizinische Wochenschrift 2014;139:251-4. [4438489]
23. Polk HC Jr, Livingston DH, Fry DE, Malangoni MA, Fabian T, Trachtenberg LS, et al. Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial. Archives of Surgery 1997;132(10):1086-92. [4438491]
24. NCT01808092 A study comparing ceftazidime-avibactam versus meropenem in hospitalized adults with nosocomial pneumonia [A phase III, randomized, multicentre, double-blind, double-dummy, parallel-group comparative study to determine the efficacy, safety and tolerability of ceftazidime-avibactam versus meropenem in the treatment of nosocomial pneumonia including ventilator-associated pneumonia in hospitalized adults]. clinicaltrials.gov/ct2/show/NCT01808092 (first received 28 February 2013). [4438493]
25. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Medicine 1996;22(5):387-94.
26. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490.
27. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American Journal of Respiratory and Critical Care Medicine 2005;171(4):388-416.
28. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Disease Society of America and the American Thoracic Society. Clinical Infectious Diseases 2016;63(5):e61-e111. [DOI: 10.1093/cdi/ciw353]
29. Chastre J, Fagon JY. Ventilator-associated pneumonia. American Journal of Respiratory and Critical Care Medicine 2002;165(7):867-903.
30. Fagon JY, Rello J. Targeted antibiotic management of ventilator-associated pneumonia. Clinical Microbiology and Infection 2006;12(Suppl 9):17-22.
31. Garnacho-Montero J, Sa-Borges M, Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, et al. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Critical Care Medicine 2007;35(8):1888-95.
32. GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed prior to 7 October 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2015.
33. Higgins JP, Green S, editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. Chichester: Wiley-Blackwell.
34. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 2005;5:13. [http://vassarstats.net/median_range.html]
35. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122(1):262-8.
36. Kim JH, Gallis HA. Observations on spiraling empiricism: its causes, allure, and perils, with particular reference to antibiotic therapy. American Journal of Medicine 1989;87(2):201-6.
37. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128(6):3854-62.
38. Kuti EL, Patel AA, Coleman CI. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. Journal of Critcal Care 2008;23(1):91-100.
39. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. Chichester: Wiley-Blackwell.
40. Liberati A, D'Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD000022.pub2]
41. Magill SS, Edwards JR, Beldavs ZG, Dumyati G, Janelle SJ, Kainer MA, et al. Prevalence of antimicrobial use in US acute care hospitals, May-September 2011. JAMA 2014;312(14):1438-46.
42. Masterton RG, Galloway A, French G, Street M, Armstrong J, Brown E, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy. Journal of Antimicrobial Chemotherapy 2008;62(1):5-34.
43. Meslen WG, Rovers MM, Groenwold R, Bergmans D, Camus C, Bauer TT, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infectious Disease 2013;13:665-71. [DOI: 10.1016]
44. Rello J. Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia. European Respiratory Review 2007;16:33-9.
45. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
46. Rubinstein E, Cammarata S, Oliphant T, Wunderink R. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clinical Infectious Diseases 2001;32(3):402-12.
47. Schreiber MP, Chan CM, Shorr AF. Resistant pathogens in non-nosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia?. Chest 2010;137(6):1283-8.
48. Torres A, Carlet J, European Task Force on ventilator-associated pneumonia. Ventilator-associated pneumonia. European Respiratory Journal 2001;17(5):1034-45.
49. West M, Boulanger B, Fogarty C, Tennenberg A, Wiesinger B, Oross M, et al. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study. Clinical Therapeutics 2003;25(2):485-506.
50. Wunderink RG, Cammarata S, Oliphant T, Kollef M. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clinical Therapeutics 2003;25(3):980-92.
51. Aarts MW, Hancock JN, Heyland DK, Marshall JC. Antibiotics for ventilator-associated pneumonia. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD004267]
52. Selim AG, Balalis G, Bhaskar B, van Driel ML. Antibiotics for ventilator-associated pneumonia. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD004267.pub3]